Weight-loss slimming capsules pose potential health risks, Health Canada warns
- March 15, 2007 8:30 AM
- By Peter Hadzipetros
Health Canada is warning consumers that MIAOZI Slimming Capsules could trigger serious health problems.
The product, manufactured by Bainian Pharmacy Group of Hong Kong, is marketed as a weight-loss product. Tests have shown the capsules contain sibutramine, a prescription medicine that suppresses the appetite but should only be taken under medical supervision.
Side effects of sibutramine include increased blood pressure, chest pain and stroke. People who have cardiovascular problems or are suffering from depression should not take the drug.
The products are not authorized for sale in Canada but may have been purchased by Canadians travelling abroad or by consumers over the internet.
Consumers can contact Health Canada for more information at (613) 957-2991, or toll free at 1-866-225-0709.
About the Authors
- Tara Kimura
is a multimedia producer for CBCNews.ca.
Categories
Recent Entries
- Seymour Custom Solvent recalled over labelling
- Health Canada has recalled 16,000 Seymour Custom Solvent Blend and Water Blend aerosol products because they do not meet mandatory warning labelling requirements.... Continue reading this post
- Kids eyeglass cases recalled because of lead levels
- About 1,500 childrens' eyeglass cases have been recalled because paint on the cases contains lead levels in excess of federal standards.... Continue reading this post
- GUND board books pose choking hazard
- GUND Inc. and Health Canada have recalled three baby books because they come with a plastic handle that can separate from the book bind and pose a choking hazard.... Continue reading this post